Analystreport

NovoCure (NASDAQ:NVCR) had its price target lowered by analysts at JPMorgan Chase & Co. from $25.00 to $23.00. They now have a "neutral" rating on the stock.

NovoCure Limited - Ordinary Shares  (NVCR) 
Last novocure limited - ordinary shares earnings: 4/30 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: novocure.com/investor-relations